/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Announces Acquisition of French Wellness Company, GreenLeaf
Immediate access to French wellness market and established portfolio
of hemp-based wellness products
LONDON–(BUSINESS WIRE)–EMMAC Life Sciences Ltd, the European independent medical cannabis
company, is pleased to announce the acquisition of GreenLeaf, a French
hemp-based wellness company. The acquisition provides EMMAC with an
established e-commerce and retail distribution model in France as well
as a proven portfolio of hemp-based wellness products, under the Hello
Joya brand.
The GreenLeaf team will strengthen EMMAC’s regional presence in France,
led by General Manager Francois-Xavier Nottin. Aurélien Delecroix,
founder of GreenLeaf, is also the founder and President of Le Syndicat
du Chanvre /The Hemp Trade Union, created in 2018 to bring together the
professional actors of the hemp and therapeutic hemp sectors in France
(production, processing, distribution) and defend their interests in the
construction of these emerging markets.
Antonio Costanzo, CEO of EMMAC, commented: “We are pleased to
announce the acquisition of GreenLeaf and welcome Aurélien and the team
to EMMAC. France is an important market for EMMAC and we are confident
that GreenLeaf’s established distribution model, experienced team and
premium product portfolio will advance our plans for strategic growth in
the region. We look forward to incorporating the Hello Joya products
into our Wellness range, as EMMAC capitalises on the rapid growth across
Europe as the cosmetic, food and nutraceutical industries incorporate
the active principles of the cannabis plant to its products.”
Aurélien Delecroix, founder of GreenLeaf, said: “We are delighted
to have joined EMMAC today. We believe our vision to help consumers
discover benefits of hemp, by producing, shaping and marketing high
quality hemp-based products aligns with EMMAC’s vision of bringing
premium quality wellness and CBD products to market, and we look forward
to extending our range for customers in France and across Europe.”
GreenLeaf is EMMAC’s second wellness company acquisition, following on
from the acquisition of Blossom, the premium wellness CBD company in
Switzerland acquired earlier in 2019.
-Ends-
About EMMAC
EMMAC is the European medical cannabis company, working to join together
the latest science and research with cutting-edge cultivation,
extraction and production. With supply and distribution partnerships
throughout Europe, EMMAC is working to establish itself as both a
thought leader in the industry, as well as the European leader in the
production and supply of medical cannabis, hemp and other derivative
products.
CAUTIONARY STATEMENT
All statements, other than statements of historical fact, in this news
release are forward-looking statements that involve various risks and
uncertainties, including, without limitation, statements regarding
potential values, the future plans and objectives of EMMAC Life Sciences
Ltd. There can be no assurance that such statements will prove to be
accurate, achievable or recognisable in the near term.
Actual results and future events could differ materially from those
anticipated in such statements. These and all subsequent written and
oral forward-looking statements are based on the estimates and opinions
of management on the dates they are made and are expressly qualified in
their entirety by this notice. EMMAC Life Sciences Ltd assumes no
obligation to update forward-looking statements should circumstances or
management’s estimates or opinions change.
Contacts
For scientific enquiries please contact [email protected]
For
general enquiries please contact [email protected]
or visit www.emmac.com
Media enquiries
Buchanan
Henry Harrison-Topham /
Jamie Hooper / Ariadna Peretz
[email protected]
Tel:
+44 (0) 20 7466 5000
www.buchanan.uk.com
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Humboldt
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia
SAN FRANCISCO, April 30, 2024 /PRNewswire/ — Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.
The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21% and four high-THC strains in the 30-35% range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Creampop. These selections represent the top .01% from HSC’s extensive California pheno-hunting program.
Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.
“Access for all to quality genetics has been our core focus since the beginning,” said HSC Co-founder and Chief Science Officer, Benjamin Lind. “Our science-based approach to breeding aligns perfectly with Apollo Green’s high standards and we are excited to be able to extend these hand-selected cuts to a wider audience, especially at this pivotal time where we’re seeing positive regulatory changes globally.”
Oisin Tierney, Apollo Green Director of Business Development, said, “California has long been recognized for setting industry standards, and we are proud to play a role in bringing these esteemed genetics to cultivators worldwide. The triploids are especially noteworthy in terms of the unprecedented potential for enhanced plant vigor, higher yields, shorter flowering times and superior returns for solventless extraction.”
About Humboldt Seed Company
Established in 2001, Humboldt Seed Company is a Northern California heritage brand providing quality cannabis genetics to commercial cultivators and home growers in legalized states across the U.S. and international markets including Spain, Canada, Jamaica, South Africa, Colombia, France, Portugal, Greece, the UK, Malta and Thailand. With a focus on environmental and social justice, they combine traditional breeding and modern scientific practices in their strain development program. They have served the cannabis community for over two decades.
For more information visit https://humboldtseedcompany.com/.
About Apollo Green
Licensed since 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients and recreational consumers. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics.
For more information visit https://apollogreen.com/.
Media contact
Jaana Prall
[email protected]
Logo – https://mma.prnewswire.com/media/2328955/Humboldt_Seed_Company_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace-302131618.html
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan1 week ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE3 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis2 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace